Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$5.33
+1.7%
$5.28
$3.42
$6.91
$294.60M1.752.48 million shs941,857 shs
Aphria Inc. stock logo
APHA
Aphria
$15.38
$15.48
$2.78
$32.29
$4.87B2.6721.83 million shsN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$24.34
+0.3%
$24.30
$19.20
$25.83
N/AN/A131,328 shs94,767 shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.88
+1.7%
C$6.18
C$5.09
C$6.55
C$576.00M0.05154363,000 shs19,510 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+1.72%-1.30%+4.72%+5.54%-4.65%
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
+0.31%-0.51%-0.08%+0.77%-2.07%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
+1.73%+1.91%-5.62%-3.76%+3.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$5.33
+1.7%
$5.28
$3.42
$6.91
$294.60M1.752.48 million shs941,857 shs
Aphria Inc. stock logo
APHA
Aphria
$15.38
$15.48
$2.78
$32.29
$4.87B2.6721.83 million shsN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$24.34
+0.3%
$24.30
$19.20
$25.83
N/AN/A131,328 shs94,767 shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.88
+1.7%
C$6.18
C$5.09
C$6.55
C$576.00M0.05154363,000 shs19,510 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+1.72%-1.30%+4.72%+5.54%-4.65%
Aphria Inc. stock logo
APHA
Aphria
0.00%0.00%0.00%0.00%0.00%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
+0.31%-0.51%-0.08%+0.77%-2.07%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
+1.73%+1.91%-5.62%-3.76%+3.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
2.80
Moderate BuyN/AN/A
Aphria Inc. stock logo
APHA
Aphria
0.00
N/AN/AN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.33
BuyC$7.1521.60% Upside

Current Analyst Ratings Breakdown

Latest EVT, ACB, HIK, APHA, and GUD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/6/2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/27/2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
8/8/2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell
(Data available from 10/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$246.72M1.21$0.62 per share8.57$7.78 per share0.69
Aphria Inc. stock logo
APHA
Aphria
$405.96M12.00$0.09 per share166.43$4.80 per share3.20
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$52.67MN/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$384.56M1.52C$1.53 per share3.85C$7.65 per share0.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$1.63M-$0.19N/A12.11N/A-5.66%-1.49%-1.06%11/5/2025 (Estimated)
Aphria Inc. stock logo
APHA
Aphria
-$63.21M-$0.06N/A219.71N/A-36.10%-2.30%-1.66%N/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73MN/AN/AN/A-8.81%-4.04%0.51%N/A

Latest EVT, ACB, HIK, APHA, and GUD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2025Q2 2026
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.03N/AN/AN/A$86.45 millionN/A
8/6/2025Q1 2026
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.18-$0.19-$0.37-$0.20$96.83 million$71.98 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Aphria Inc. stock logo
APHA
Aphria
N/AN/AN/AN/AN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$2.148.79%N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A

Latest EVT, ACB, HIK, APHA, and GUD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/1/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.12%10/15/202510/15/202510/31/2025
9/2/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.18%9/15/20259/15/20259/30/2025
8/1/2025
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16468.3%8/15/20258/15/20258/29/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.06
2.97
1.51
Aphria Inc. stock logo
APHA
Aphria
0.25
2.36
1.17
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13056.22 million56.22 millionOptionable
Aphria Inc. stock logo
APHA
Aphria
1,200316.80 millionN/AOptionable
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/ANot Optionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
72599.65 millionN/ANot Optionable

Recent News About These Companies

Is Knight Therapeutics stock a buy?
Knight Therapeutics is a buy, Stifel says
Collective, Knight at 52-Week Highs on News
Sime Armoyan selling more Knight Therapeutics (GUD)
Endo divests Paladin business

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$5.33 +0.09 (+1.72%)
Closing price 10/20/2025 04:00 PM Eastern
Extended Trading
$5.36 +0.03 (+0.58%)
As of 09:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aphria stock logo

Aphria NASDAQ:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Eaton Vance Tax-Advantaged Dividend Income Fund NYSE:EVT

$24.34 +0.08 (+0.31%)
Closing price 10/20/2025 03:57 PM Eastern
Extended Trading
$24.33 -0.01 (-0.02%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.

Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$5.88 +0.10 (+1.73%)
As of 10/20/2025 04:00 PM Eastern

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.